256 Newsroom — Uganda's Digital News Infrastructure
Business

Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal - fiercebiotech.com

Published by FierceBiotech By Nick Paul Taylor · 13 August 2026 at 13:00
Share
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal - fiercebiotech.com
Image · FierceBiotech

What the report says

Taiho Pharmaceutical and Cullinan Therapeutics have

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Equity trade mission puts Uganda’s investment potential in spotlightNile Post Ibanda Traders Report Slow Scholastic Sales as Third Term OpensNile Post 256 Newsroom Dangerous taxis return to Kampala roads despite 100-day crackdown - monitor.co.ugDaily Monitor 256 Newsroom Dry spell, low prices squeeze coffee farmers in Buganda - monitor.co.ugDaily Monitor Qcil Calls for Stronger Uganda–Nigeria Collaboration to Boost Pharmaceutical ManufacturingNile Post Vivo Energy Bets on Mobile Training Academies to Upskill Shell Station Employees,Mechanics CountrywideNile Post